Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 23266396)

1.

Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.

Takeuchi C, Matsumoto Y, Kohyama K, Uematsu S, Akira S, Yamagata K, Takemiya T.

Neurochem Int. 2013 Feb;62(3):271-80. doi: 10.1016/j.neuint.2012.12.007. Epub 2012 Dec 22.

PMID:
23266396
2.

Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis.

Kihara Y, Matsushita T, Kita Y, Uematsu S, Akira S, Kira J, Ishii S, Shimizu T.

Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21807-12. doi: 10.1073/pnas.0906891106. Epub 2009 Dec 7.

3.

Microsomal prostaglandin E synthase 1 deletion retards renal disease progression but exacerbates anemia in mice with renal mass reduction.

Jia Z, Wang H, Yang T.

Hypertension. 2012 Jan;59(1):122-8. doi: 10.1161/HYPERTENSIONAHA.111.178897. Epub 2011 Nov 21.

4.

Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.

Virgili N, Espinosa-Parrilla JF, Mancera P, Pastén-Zamorano A, Gimeno-Bayon J, Rodríguez MJ, Mahy N, Pugliese M.

J Neuroinflammation. 2011 Nov 2;8:149. doi: 10.1186/1742-2094-8-149.

5.

Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis.

Sasaki Y, Kamei D, Ishikawa Y, Ishii T, Uematsu S, Akira S, Murakami M, Hara S.

Oncogene. 2012 Jun 14;31(24):2943-52. doi: 10.1038/onc.2011.472. Epub 2011 Oct 10.

PMID:
21986945
6.

Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation.

Brenneis C, Coste O, Altenrath K, Angioni C, Schmidt H, Schuh CD, Zhang DD, Henke M, Weigert A, Brüne B, Rubin B, Nusing R, Scholich K, Geisslinger G.

J Biol Chem. 2011 Jan 21;286(3):2331-42. doi: 10.1074/jbc.M110.157362. Epub 2010 Nov 12.

7.

Endothelial microsomal prostaglandin E synthase-1 facilitates neurotoxicity by elevating astrocytic Ca2+ levels.

Takemiya T, Matsumura K, Sugiura H, Yasuda S, Uematsu S, Akira S, Yamagata K.

Neurochem Int. 2011 Mar;58(4):489-96. doi: 10.1016/j.neuint.2011.01.003. Epub 2011 Jan 8.

PMID:
21219953
8.

Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages.

Xiao L, Ornatowska M, Zhao G, Cao H, Yu R, Deng J, Li Y, Zhao Q, Sadikot RT, Christman JW.

PLoS One. 2012;7(11):e50244. doi: 10.1371/journal.pone.0050244. Epub 2012 Nov 30.

9.

Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production.

Ikeda-Matsuo Y, Ikegaya Y, Matsuki N, Uematsu S, Akira S, Sasaki Y.

J Neurochem. 2005 Sep;94(6):1546-58. Epub 2005 Jul 5.

PMID:
16000148
10.

Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicity.

Ikeda-Matsuo Y, Hirayama Y, Ota A, Uematsu S, Akira S, Sasaki Y.

Br J Pharmacol. 2010 Mar;159(5):1174-86. doi: 10.1111/j.1476-5381.2009.00595.x. Epub 2010 Jan 29.

11.

Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.

Ballerini C, Aldinucci A, Luccarini I, Galante A, Manuelli C, Blandina P, Katebe M, Chazot PL, Masini E, Passani MB.

Br J Pharmacol. 2013 Sep;170(1):67-77. doi: 10.1111/bph.12263.

12.

Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).

Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS.

J Neuroimmunol. 2008 Oct 15;203(1):79-93. doi: 10.1016/j.jneuroim.2008.06.030.

PMID:
18687476
13.

A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.

Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, Warren K, Power C.

J Neurosci. 2004 Feb 11;24(6):1521-9.

14.
15.

MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.

Xu D, Rowland SE, Clark P, Giroux A, Côté B, Guiral S, Salem M, Ducharme Y, Friesen RW, Méthot N, Mancini J, Audoly L, Riendeau D.

J Pharmacol Exp Ther. 2008 Sep;326(3):754-63. doi: 10.1124/jpet.108.138776. Epub 2008 Jun 4.

16.

Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.

de Lago E, Moreno-Martet M, Cabranes A, Ramos JA, Fernández-Ruiz J.

Neuropharmacology. 2012 Jun;62(7):2299-308. doi: 10.1016/j.neuropharm.2012.01.030. Epub 2012 Feb 8.

PMID:
22342378
17.

Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis.

Terayama R, Bando Y, Yamada M, Yoshida S.

Glia. 2005 Nov 1;52(2):108-18.

PMID:
15920728
18.

c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes.

Degousee N, Angoulvant D, Fazel S, Stefanski E, Saha S, Iliescu K, Lindsay TF, Fish JE, Marsden PA, Li RK, Audoly LP, Jakobsson PJ, Rubin BB.

J Biol Chem. 2006 Jun 16;281(24):16443-52. Epub 2006 Apr 19.

20.

Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders.

Yamakawa K, Kamekura S, Kawamura N, Saegusa M, Kamei D, Murakami M, Kudo I, Uematsu S, Akira S, Chung UI, Nakamura K, Kawaguchi H.

Arthritis Rheum. 2008 Jan;58(1):172-83. doi: 10.1002/art.23158.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk